Mario Tanguay

Employment

• Université de Montréal Adjunct Professor
• Syneos Health Vice President, Clinical Development

Education

• Université de Montréal MSc
• Université de Montréal PhD
• Université de Montréal B.Pharm

Projects & Funding

Projects & funding information is unavailable.

Publications (28)

• Review of Drugs Approved via the 505(b)(2) Pathway: Uncovering Drug Development Trends and Regulatory Requirements
  Therapeutic Innovation & Regulatory Science 2020 DOI: 10.1007/s43441-019-00036-y
  +Save
• A Pharmacokinetic Bioequivalence Study Comparing Sublingual Riluzole (BHV-0223) and Oral Tablet Formulation of Riluzole in Healthy Volunteers.
  Clinical pharmacology in drug development 2019 DOI: 10.1002/cpdd.747
  +Save
• Review of Drugs Approved via the 505(b)(2) Pathway: Uncovering Drug Development Trends and Regulatory Requirements.
  Therapeutic innovation & regulatory science 2019 DOI: 10.1177/2168479018811889
  +Save
• A randomized, open-label study assessing the bioequivalence of two formulations of Fingolimod 0.5 mg in healthy subjects
  AAPS Open 2018 DOI: 10.1186/s41120-018-0023-3
  +Save
• Pharmacokinetics and Comparative Bioavailability of a Levothyroxine Sodium Oral Solution and Soft Capsule.
  Clinical pharmacology in drug development 2018 DOI: 10.1002/cpdd.608
  +Save
• Modelling the dose-response relationship: the fair share of pharmacokinetic and pharmacodynamic information.
  British journal of clinical pharmacology 2017 DOI: 10.1111/bcp.13225
  +Save
• Modeling Testosterone Circadian Rhythm in Hypogonadal Males: Effect of Age and Circannual Variations.
  The AAPS journal 2015 DOI: 10.1208/s12248-015-9841-6
  +Save
• Population pharmacokinetic and pharmacodynamic analysis of tesamorelin in HIV-infected patients and healthy subjects.
  Journal of pharmacokinetics and pharmacodynamics 2015 DOI: 10.1007/s10928-015-9416-2
  +Save
• Population pharmacokinetic analysis of tesamorelin in HIV-infected patients and healthy subjects.
  Clinical pharmacokinetics 2015 DOI: 10.1007/s40262-014-0202-x
  +Save
• Pharmacokinetic characterization of baclofen in patients with chronic kidney disease: dose adjustment recommendations.
  Journal of clinical pharmacology 2014 DOI: 10.1002/jcph.247
  +Save